(Q35885137)

10 August 2017

1 reference

title

Pharmacoeconomic implications of new therapies in sepsis (English)

1 reference

10 August 2017

0 references

2

Derek C Angus

1 reference

10 August 2017

Kelly A Wood

1

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

22

1 reference

10 August 2017

issue

14

1 reference

10 August 2017

page(s)

895-906

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-200422140-00001

10 August 2017

exact match

0 references

cites work

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

1 reference

12 December 2020

Continuous subglottic suctioning for the prevention of ventilator-associated pneumonia : potential economic implications

1 reference

12 December 2020

Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society workshop on outcomes research

1 reference

12 December 2020

Improving clinical trial design in acute lung injury

1 reference

12 December 2020

Adrenal insufficiency in critically ill patients

1 reference

12 December 2020

The nationwide nosocomial infection rate. A new need for vital statistics

1 reference

12 December 2020

Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock

1 reference

12 December 2020

A comparison of work-sampling and time-and-motion techniques for studies in health services research

1 reference

12 December 2020

Long-term outcome of critically ill elderly patients requiring intensive care.

1 reference

12 December 2020

Surviving intensive care: a report from the 2002 Brussels Roundtable.

1 reference

12 December 2020

One-year outcomes in survivors of the acute respiratory distress syndrome.

1 reference

12 December 2020

From the Centers for Disease Control. Increase in National Hospital Discharge Survey rates for septicemia--United States, 1979-1987

1 reference

12 December 2020

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

1 reference

12 December 2020

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

12 December 2020

Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group

1 reference

12 December 2020

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

1 reference

12 December 2020

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis

1 reference

12 December 2020

Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?

1 reference

12 December 2020

The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group

1 reference

12 December 2020

Long-term mortality and medical care charges in patients with severe sepsis

1 reference

12 December 2020

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment

1 reference

12 December 2020

A cost-effectiveness analysis of neonatal ECMO using existing evidence

1 reference

12 December 2020

Severe sepsis--a new treatment with both anticoagulant and antiinflammatory properties

1 reference

12 December 2020

Quality-adjusted survival in the first year after the acute respiratory distress syndrome

1 reference

12 December 2020

Characterization of neonatal personnel time inputs and prediction from clinical variables--a time and motion study.

1 reference

12 December 2020

The impact of nosocomial infections on patient outcomes following cardiac surgery.

1 reference

12 December 2020

The era of genomics: impact on sepsis clinical trial design

1 reference

12 December 2020

Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials?

1 reference

12 December 2020

Pneumonia: still the old man's friend?

1 reference

12 December 2020

Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop

1 reference

12 December 2020

Corticosteroids for patients with septic shock

1 reference

12 December 2020

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

12 December 2020

Preventing fatal diseases increases healthcare costs: cause elimination life table approach

1 reference

12 December 2020

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

12 December 2020

Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.

1 reference

12 December 2020

Corticosteroids for patients with septic shock

1 reference

12 December 2020

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

12 December 2020

Early goal-directed therapy in the treatment of severe sepsis and septic shock

1 reference

12 December 2020

Epidemiology of sepsis: an update

1 reference

12 December 2020

An economic evaluation of activated protein C treatment for severe sepsis

1 reference

12 December 2020

The epidemiology of sepsis in the United States from 1979 through 2000

1 reference

12 December 2020

Steroid controversy in sepsis and septic shock: a meta-analysis

1 reference

12 December 2020

Does acute organ dysfunction predict patient-centered outcomes?

1 reference

12 December 2020

Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue

1 reference

12 December 2020

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study

1 reference

12 December 2020

Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction

1 reference

12 December 2020

Corticosteroids for Patients With Septic Shock

1 reference

12 December 2020

Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States

1 reference

12 December 2020

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine

1 reference

12 December 2020

Economic evaluations in the critical care literature: do they help us improve the efficiency of our unit?

1 reference

12 December 2020

APACHE II: a severity of disease classification system

1 reference

12 December 2020

10.2165/00019053-200422140-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1006870406

0 references

1 reference